Chemours Company (CC Quick QuoteCC - Free Report) , a chemical company that has organized its business in three segments, namely, Titanium Technologies, Fluoroproducts and Chemical Solutions. With a Growth, Momentum and VGM score of “A”, the company has a whopping average positive surprise of 39.8%, with three beats over the last four quarters. It also is in the top 8% of its industry class and has an impressive expected five-year growth rate of 15.5%.

Align Technology Inc. (ALGN Quick QuoteALGN - Free Report) , designs, manufactures and markets the Invisalign System, a proprietary method for treating malocclusion. This company has one of the strongest medical technology success stories of the past year, with 27.8% sales growth in 2016 and an expected 25%+ top line ramp in 2017. First quarter company earnings, reported on April 27, confirmed that the growth story for the $11.4 billion maker of the revolutionary dental technology Invisalign is well intact. Its strong cash balance enables it to adopt attractive share repurchase programs.

Zacks' 2017 IPO Watch List

Before looking into the stocks mentioned above, you may want to get a head start on potential tech IPOs that are popping up on Zacks' radar. Imagine being in the first wave of investors to jump on a company with almost unlimited growth potential? This Special Report gives you the current scoop on 5 that may go public at any time.

One has driven from 0 to a $68 billion valuation in 8 years. Four others are a little less obvious but already show jaw-dropping growth. Download this IPO Watch List today for free >>